Literature DB >> 7442460

Decrease in lymphocyte [3H]spiroperidol binding sites in Parkinsonism.

G Le Fur, V Meininger, T Phan, A Gérard, M Baulac, A Uzan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7442460     DOI： 10.1016/0024-3205(80)90568-8

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  6 in total

1.  mRNA expression of dopamine receptors in peripheral blood lymphocytes of computer game addicts.

Authors:  Nasim Vousooghi; Seyed Zeinolabedin Zarei; Mitra-Sadat Sadat-Shirazi; Fatemeh Eghbali; Mohammad Reza Zarrindast
Journal:  J Neural Transm (Vienna)       Date:  2015-05-14       Impact factor: 3.575

2.  Failure of a peripheral dopaminergic marker in Parkinson's disease.

Authors:  J M Maloteaux; C E Laterre; L Hens; P M Laduron
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-12       Impact factor: 10.154

3.  Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia.

Authors:  Amarendra N Singh; Cia Barlas; Huma Saeedi; Ram K Mishra
Journal:  J Psychiatry Neurosci       Date:  2003-01       Impact factor: 6.186

Review 4.  The immunoregulatory role of dopamine: an update.

Authors:  Chandrani Sarkar; Biswarup Basu; Debanjan Chakroborty; Partha Sarthi Dasgupta; Sujit Basu
Journal:  Brain Behav Immun       Date:  2009-11-05       Impact factor: 7.217

5.  Dopamine receptors in human lymphocytes: radioligand binding and quantitative RT-PCR assays.

Authors:  Galina P Kirillova; Rebecca J Hrutkay; Michael R Shurin; Galina V Shurin; Irina L Tourkova; Michael M Vanyukov
Journal:  J Neurosci Methods       Date:  2008-08-05       Impact factor: 2.390

6.  The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders.

Authors:  Francesca R Buttarelli; Alessandra Fanciulli; Clelia Pellicano; Francesco E Pontieri
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.